HYEX · XBRL financial data

Healthy Extracts financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (HYEX's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23†Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	614	669*	689	908	745	771*	931	969	918	1,694*	1,611	2,067
Cost of revenue	120	103*	280	422	142	357*	506	376	471	737*	622	615
Cost of goods and services sold	120	103*	280	422	142	357*	506	376	471	737*	622	615
Gross profit	493	566*	408	486	602	414*	425	593	447	957*	989	1,452
General and administrative	754	888*	470	498	517	609*	534	698	907	1,227*	1,317	1,501
Total operating expenses	754	888*	470	498	517	609*	534	698	907	1,227*	1,317	1,501
Interest expense	27*	—	—	—	—	—	35	(30)*	—	—	85	(16)*
Other income (expense)	13	(57)*	(799)	125	269	(253)*	(290)	173	65	115*	128	(81)
Income tax expense (benefit)	0*	0*	0	0*	0*	0*	0	0*	0*	0*	0	0*
Net income (loss)	(248)	(379)*	(861)	114	354	(447)*	(399)	67	(395)	(154)*	(201)	(129)

† Share count changed about 1/120 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (HYEX's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23†Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	46	19	87	148	100	112	119	200	189	147	164	190
Accounts receivable	109	30	24	91	20	11	70	4	31	188	254	607
Inventory	1,528	1,626	1,553	1,320	1,437	1,361	1,143	1,107	967	843	521	644
Total current assets	1,905	1,900	1,870	1,749	1,732	1,659	1,481	1,561	1,728	1,327	1,088	1,679
Right-of-use asset	86	72	57	41	25	9	0	0	0	0	—	—
Goodwill	193	193	193	193	193	193	193	193	193	21,124	21,124	26,057
Total assets	2,641	2,635	2,605	2,485	2,468	2,378	2,411	2,496	26,191	27,825	27,319	32,609
Accounts payable	69	117	118	54	43	52	81	115	121	108	149	341
Accrued liabilities	189	215	206	189	188	249	205	224	163	614	459	593
Total current liabilities	1,616	1,680	2,453	2,085	1,665	1,968	2,351	862	1,174	1,688	1,585	8,389
Lease liability, non-current	26	9	0	0	0	0	135	122	105	344	280	229
Total liabilities	—	—	—	—	—	1,968	—	2,018	2,130	3,795	3,337	10,173
Accumulated deficit	(18,021)	(18,400)	(19,261)	(19,147)	(18,793)	(19,240)	(19,639)	(19,572)	(19,967)	(20,121)	(20,322)	(20,451)
Total stockholders' equity	1,024	955	152	400	803	410	61	478	24,062	24,030	23,982	22,436
Total liabilities and equity	2,641	2,635	2,605	2,485	2,468	2,378	2,411	2,496	26,191	27,825	27,319	32,609
Common shares outstanding (cover page) thousands of shares	354,492	2,964	2,964	2,994	2,989	2,989	3,137	16,871	16,871	16,891	16,891	14,741

† Share count changed about 1/120 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (HYEX's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23†Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(248)	(379)*	(861)	114	354	(447)*	(399)	67	(395)	(154)*	(201)	(129)
Net cash from operating activities	(68)*	56*	19	169*	52*	42*	60	17*	(280)*	368*	106	306*
Purchases of property and equipment	0*	0*	0	0*	—	—	—	—	—	—	—	—
Net cash from investing activities	0*	0*	0	0*	0*	0*	0	(19)*	0*	76*	0	96*
Proceeds from issuing common stock	(35)*	(55)*	0	0*	0*	0*	0	0*	—	—	—	—
Net cash from financing activities	22*	(83)*	49	(108)*	(100)*	(30)*	(53)	84*	269*	(486)*	(89)	(376)*
Net change in cash	(46)*	(27)*	68	61*	(48)*	12*	7	82*	(11)*	(43)*	17	26*

† Share count changed about 1/120 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 2833 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2833 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Healthy Extracts	190	2,067	306*	14.7M	—	Q2 FY26 10-QJun 30, 2026
Theriva Biologics	11,337	0*	(3,085)*	45.9M	3.7 quarters	Q2 FY26 10-QJun 30, 2026
China Pharma Holdings	305	948	(33)*	43.0M	9.3 quarters	Q2 FY26 10-QJun 30, 2026
Jaguar Health	3,788	1,225	(5,338)*	not reported	0.7 quarters	Q2 FY26 10-QJun 30, 2026
Synlogic	13,183	0	(922)*	12.2M	14.3 quarters	Q2 FY26 10-QJun 30, 2026
Matinas BioPharma Holdings	761	not reported	(1,836)*	14.7M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
Soligenix	9,811	not reported	(1,707)*	21.8M	5.7 quarters	Q2 FY26 10-QJun 30, 2026
Q/C Technologies	308	not reported	(1,819)*	8.2M	6.0 quarters	Q2 FY26 10-QJun 30, 2026
Polomar Health Services	179	1,529	121*	28.4M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.